A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.

Abstract

To comprehensively investigate nasopharyngeal carcinoma (NPC) treatment, overall survival (OS), and the influence of clinical/sociodemographic factors on outcome. Retrospective database study. National Cancer Database. The 2004-2015 National Cancer Database was queried for all patients with NPC receiving definitive treatment. Log-rank tests and Cox proportional hazards models were used for statistical analyses. A total of 8260 patients with NPC were included (71.4% male; 42.5% with keratinizing histology; mean ± SD age, 52.1 ± 15.1 years), with a 5-year OS of 63.4%. Multivariate predictors of mortality included age ≥65 years (hazard ratio [HR], 1.81; <i>P</i> < .001), Charlson/Deyo score ≥1 (HR, 1.27; <i>P</i> = .001), American Joint Committee on Cancer clinical stage III to IV (HR, 1.85; <i>P</i> < .001), and government insurance or no insurance (HR, 1.53; <i>P</i> < .001). Predictors of survival included female sex (HR, 0.82; <i>P</i> = .002), Asian/Pacific Islander race (HR, 0.74; <i>P</i> < .001), nonkeratinizing/undifferentiated histology (HR, 0.79; <i>P</i> = .004), and receiving treatment at academic centers (HR, 0.87; <i>P</i> = .02). Chemoradiotherapy (CRT) demonstrated improved OS as compared with radiotherapy (RT) only for stage II (<i>P</i> = .006) and stage III (<i>P</i> = .005) and with RT or chemotherapy only in stage IVA NPC (<i>P</i> < .001). When compared with CRT alone, surgery plus CRT provided OS benefits in keratinizing (<i>P</i> = .013) or stage IVA (<i>P</i> = .030) NPC. When compared with RT, CRT provided OS benefits in keratinizing (<i>P</i> = .005) but not nonkeratinizing (<i>P</i> = .240) or undifferentiated (<i>P</i> = .390) NPC. Substandard radiation dosing of <60 Gy and <30 fractions were associated with inferior OS (both <i>P</i> < .001). NPC survival is dependent on a variety of clinical/sociodemographic factors. Stage-specific treatments with optimal OS include CRT or RT for stages I to II and CRT for stage III to IV. The large representation of nonendemic histology is valuable, as these cases are not well characterized.